• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内科住院患者静脉血栓栓塞症和出血风险模型:系统识别与专家评估。

Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment.

机构信息

Michael G. DeGroote Cochrane Canada Centre.

McMaster GRADE Centre.

出版信息

Blood Adv. 2020 Jun 23;4(12):2557-2566. doi: 10.1182/bloodadvances.2020001937.

DOI:10.1182/bloodadvances.2020001937
PMID:32542391
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7322970/
Abstract

Risk assessment models (RAMs) for venous thromboembolism (VTE) and bleeding in hospitalized medical patients inform appropriate use of thromboprophylaxis. Our aim was to use a novel approach for selecting risk factors for VTE and bleeding to be included in RAMs. First, we used the results of a systematic review of all candidate factors. Second, we used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to assess the certainty of the evidence for the identified factors. Third, we using a structured approach to select factors to develop the RAMs, by building on clinical and methodological expertise. The expert panel made judgments on whether to include, potentially include, or exclude risk factors, according to domains of the GRADE approach and the Delphi method. The VTE RAM included age >60 years, previous VTE, acute infections, immobility, acute paresis, active malignancy, critical illness, and known thrombophilia. The bleeding RAM included age ≥65 years, renal failure, thrombocytopenia, active gastroduodenal ulcers, hepatic disease, recent bleeding, and critical illness. We identified acute infection as a factor that was not considered in widely used RAMs. Also, we identified factors that require further research to confirm or refute their importance in a VTE RAM (eg, D-dimer). We excluded autoimmune disease which is included in the IMPROVE (International Medical Prevention Registry on Venous Thromboembolism) bleeding RAM. Our results also suggest that sex, malignancy, and use of central venous catheters (factors in the IMPROVE bleeding RAM) require further research. In conclusion, our study presents a novel approach to systematically identifying and assessing risk factors to be included or further explored during RAM development.

摘要

风险评估模型(RAM)可用于评估静脉血栓栓塞症(VTE)和住院患者出血风险,从而为合理使用血栓预防措施提供依据。本研究旨在采用一种新方法,筛选可纳入 RAM 的 VTE 和出血风险因素。首先,我们对所有候选因素进行系统评价,以确定潜在风险因素。其次,我们采用 GRADE 方法评估这些因素的证据确定性。最后,我们采用一种结构化方法,基于临床和方法学专业知识选择因素,以开发 RAM。专家组根据 GRADE 方法和 Delphi 方法的各个领域,对是否纳入、潜在纳入或排除风险因素做出判断。VTE RAM 包括年龄>60 岁、既往 VTE、急性感染、活动受限、急性瘫痪、活动性恶性肿瘤、重症和已知易栓症。出血 RAM 包括年龄≥65 岁、肾衰竭、血小板减少、活动性胃十二指肠溃疡、肝脏疾病、近期出血和重症。本研究还确定了急性感染是目前广泛应用的 RAM 中未考虑的因素。此外,我们还确定了一些因素,需要进一步研究以确认或反驳它们在 VTE RAM 中的重要性(例如 D-二聚体)。我们排除了自身免疫性疾病,因为它被纳入了 IMPROVE(国际静脉血栓栓塞症预防注册研究)出血 RAM 中。本研究结果还表明,性别、恶性肿瘤和中央静脉导管的使用(IMPROVE 出血 RAM 中的因素)需要进一步研究。总之,本研究提出了一种系统地识别和评估风险因素的新方法,可用于 RAM 开发或进一步探索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/7322970/6cc8e00d9ba8/advancesADV2020001937absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/7322970/6cc8e00d9ba8/advancesADV2020001937absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/7322970/6cc8e00d9ba8/advancesADV2020001937absf1.jpg

相似文献

1
Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment.内科住院患者静脉血栓栓塞症和出血风险模型:系统识别与专家评估。
Blood Adv. 2020 Jun 23;4(12):2557-2566. doi: 10.1182/bloodadvances.2020001937.
2
Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis.住院内科患者静脉血栓栓塞症和出血的预后因素:系统评价和荟萃分析。
Blood. 2020 May 14;135(20):1788-1810. doi: 10.1182/blood.2019003603.
3
A Prospective Observational Cohort of Clinical Outcomes in Medical Inpatients prescribed Pharmacological Thromboprophylaxis Using Different Clinical Risk Assessment Models(COMPT RAMs).采用不同临床风险评估模型(COMPT RAMs)对住院患者进行药物性血栓预防治疗的前瞻性观察性队列研究的临床结局。
Sci Rep. 2019 Dec 4;9(1):18366. doi: 10.1038/s41598-019-54842-3.
4
Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review.急性病内科患者静脉血栓栓塞症的风险评估模型。一项系统评价。
Thromb Haemost. 2017 Apr 3;117(4):801-808. doi: 10.1160/TH16-08-0631. Epub 2017 Feb 2.
5
Comparative Performance of Clinical Risk Assessment Models for Hospital-Acquired Venous Thromboembolism in Medical Patients.医学患者医院获得性静脉血栓栓塞症临床风险评估模型的比较性能。
Thromb Haemost. 2018 Jan;118(1):82-89. doi: 10.1160/TH17-06-0403. Epub 2018 Jan 5.
6
Risk Assessment Models for Venous Thromboembolism in Medical Inpatients.内科住院患者静脉血栓栓塞风险评估模型。
JAMA Netw Open. 2024 May 1;7(5):e249980. doi: 10.1001/jamanetworkopen.2024.9980.
7
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews.住院内科患者静脉血栓栓塞症和出血风险评估模型:系统评价概述。
Blood Adv. 2020 Oct 13;4(19):4929-4944. doi: 10.1182/bloodadvances.2020002482.
8
Risk assessment models for venous thromboembolism in hospitalised adult patients: a systematic review.住院成年患者静脉血栓栓塞症风险评估模型:系统评价。
BMJ Open. 2021 Jul 29;11(7):e045672. doi: 10.1136/bmjopen-2020-045672.
9
Updated clinical models for VTE prediction in hospitalized medical patients.更新的住院医疗患者静脉血栓栓塞预测临床模型。
Thromb Res. 2018 Apr;164 Suppl 1:S62-S69. doi: 10.1016/j.thromres.2018.02.004.
10
Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model.采用 Padua 预测评分和 Caprini 风险评估模型评估住院患者静脉血栓栓塞风险。
J Atheroscler Thromb. 2018 Nov 1;25(11):1091-1104. doi: 10.5551/jat.43653. Epub 2018 Mar 13.

引用本文的文献

1
Development and validation of risk models for hospital-acquired bleeding in medical inpatients: the Medical Inpatients Thrombosis and Hemostasis (MITH) study.内科住院患者医院获得性出血风险模型的开发与验证:内科住院患者血栓形成与止血(MITH)研究
J Thromb Haemost. 2025 Jul 17. doi: 10.1016/j.jtha.2025.07.007.
2
Effect of early readmission on subsequent hospital admissions within 1 year in patients with heart failure: A retrospective cohort study.心力衰竭患者早期再入院对1年内随后住院情况的影响:一项回顾性队列研究。
Medicine (Baltimore). 2025 Feb 14;104(7):e41567. doi: 10.1097/MD.0000000000041567.
3
Risk assessment models: considerations prior to use in clinical practice.

本文引用的文献

1
Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis.住院内科患者静脉血栓栓塞症和出血的预后因素:系统评价和荟萃分析。
Blood. 2020 May 14;135(20):1788-1810. doi: 10.1182/blood.2019003603.
2
Hospitalist assessment of venous thromboembolism and bleeding risk: A survey study.住院医师对静脉血栓栓塞症和出血风险的评估:一项调查研究。
Thromb Res. 2019 Jun;178:155-158. doi: 10.1016/j.thromres.2019.04.015. Epub 2019 Apr 16.
3
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.
风险评估模型:临床实践应用前的考量因素
Eye (Lond). 2025 Mar;39(4):617-619. doi: 10.1038/s41433-024-03557-5. Epub 2024 Dec 18.
4
Validation of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) risk scores for venous thromboembolism and bleeding in an independent population.国际静脉血栓栓塞症预防登记处(IMPROVE)静脉血栓栓塞症和出血风险评分在独立人群中的验证。
Res Pract Thromb Haemost. 2024 May 15;8(4):102441. doi: 10.1016/j.rpth.2024.102441. eCollection 2024 May.
5
Venous thromboembolism performance measurement in the United States: An evolving landscape with many stakeholders.美国静脉血栓栓塞症表现测量:一个利益相关者众多、不断发展的领域。
J Hosp Med. 2024 Sep;19(9):827-840. doi: 10.1002/jhm.13385. Epub 2024 May 21.
6
Comparison of the PADUA and IMPROVE scores in assessing venous thromboembolism risk in 42,257 medical inpatients in China.比较 PADUA 和 IMPROVE 评分在中国 42257 例内科住院患者中的静脉血栓栓塞风险评估。
J Thromb Thrombolysis. 2024 Jun;57(5):775-783. doi: 10.1007/s11239-024-02979-y. Epub 2024 Apr 21.
7
Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis.医院住院患者静脉血栓栓塞风险评估模型的评估:VTEAM 证据综合评价。
Health Technol Assess. 2024 Apr;28(20):1-166. doi: 10.3310/AWTW6200.
8
Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study.医院获得性静脉血栓形成风险模型的开发和验证:住院患者血栓与止血研究。
J Thromb Haemost. 2024 Feb;22(2):503-515. doi: 10.1016/j.jtha.2023.10.015. Epub 2023 Oct 31.
9
Venous thromboembolism prophylaxis for hospitalized adult patients: a survey of US health care providers on attitudes and practices.住院成年患者的静脉血栓栓塞预防:美国医疗保健提供者对态度和实践的调查。
Res Pract Thromb Haemost. 2023 Aug 7;7(6):102168. doi: 10.1016/j.rpth.2023.102168. eCollection 2023 Aug.
10
Application of artificial neural network in daily prediction of bleeding in ICU patients treated with anti-thrombotic therapy.人工神经网络在 ICU 抗血栓治疗患者出血日常预测中的应用。
BMC Med Inform Decis Mak. 2023 Aug 31;23(1):171. doi: 10.1186/s12911-023-02274-5.
美国血液学会 2018 年静脉血栓栓塞症管理指南:住院和非住院医疗患者的预防。
Blood Adv. 2018 Nov 27;2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954.
4
Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model.采用 Padua 预测评分和 Caprini 风险评估模型评估住院患者静脉血栓栓塞风险。
J Atheroscler Thromb. 2018 Nov 1;25(11):1091-1104. doi: 10.5551/jat.43653. Epub 2018 Mar 13.
5
Addressing the burden of hospital-related venous thromboembolism: the role of extended anticoagulant prophylaxis.应对医院相关静脉血栓栓塞的负担:延长抗凝预防的作用。
J Thromb Haemost. 2018 Mar;16(3):413-417. doi: 10.1111/jth.13942.
6
Clinical conundrums in antithrombotic therapy management: A Delphi Consensus panel.抗栓治疗管理中的临床难题:德尔菲共识小组。
Int J Cardiol. 2017 Dec 15;249:249-256. doi: 10.1016/j.ijcard.2017.09.159. Epub 2017 Sep 19.
7
Identifying predictors for bleeding in hospitalized cancer patients: A cohort study.确定住院癌症患者出血的预测因素:一项队列研究。
Thromb Res. 2017 Oct;158:38-43. doi: 10.1016/j.thromres.2017.08.005. Epub 2017 Aug 12.
8
Variation in Definitions of Immobility in Pharmacological Thromboprophylaxis Clinical Trials in Medical Inpatients: A Systematic Review.内科住院患者药理血栓预防临床试验中活动减少定义的差异:一项系统评价
Clin Appl Thromb Hemost. 2018 Jan;24(1):13-21. doi: 10.1177/1076029616677802. Epub 2016 Nov 15.
9
Risk assessment models for venous thromboembolism in acutely ill medical patients. A systematic review.急性病内科患者静脉血栓栓塞症的风险评估模型。一项系统评价。
Thromb Haemost. 2017 Apr 3;117(4):801-808. doi: 10.1160/TH16-08-0631. Epub 2017 Feb 2.
10
GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines.GRADE证据到决策(EtD)框架:一种用于做出明智医疗选择的系统且透明的方法。2:临床实践指南。
BMJ. 2016 Jun 30;353:i2089. doi: 10.1136/bmj.i2089.